DEFA14A ·Filed Jun 22, 2026
Proxy solicitation materials
Actionable Insight • Neutral
No trading action warranted. This is a standard post-meeting disclosure. Monitor upcoming quarterly filings for operational and financial updates on UNCY.
Final — all horizons settled through T+60d
UNCY ▼ -40.15% at T+60d
NEUTRAL call -40.15% · α vs SPY -41.90% · entry $7.87 → $4.71
T+1d
+1.91%
call +1.91% · α +3.36%
$8.02
settled 4mo ago
T+5d
-2.16%
call -2.16% · α -1.70%
$7.70
settled 4mo ago
T+20d
-31.64%
call -31.64% · α -31.49%
$5.38
settled 3mo ago
T+60d
-40.15%
call -40.15% · α -41.90%
$4.71
settled 6w ago
Price Chart
Loading chart...
Executive Summary
Unicycive Therapeutics filed a DEFA14A (as an 8-K) reporting the results of its 2025 Annual Meeting. All three director nominees were elected and the appointment of Grassi & Co. as independent auditor was ratified. This is a routine administrative filing with no material financial or strategic implications.
Key Financial Metrics
Vote
director election
Meeting
2025-06-19
Seats Contested
3
Key Facts
- Annual Meeting held June 19, 2025 (filed June 22, 2026); quorum of 14,964,159 shares represented.
- All three director nominees (Shalabh Gupta, Sandeep Laumas, D. Sarawati Kenkare-Mitra) were elected with substantial 'For' votes.
- Ratification of Grassi & Co. CPAs, P.C. as independent auditor passed with 14,667,242 votes in favor.
- Broker non-votes were significant (over 6.6 million) for director elections but not for auditor ratification.
Financial Impact
No financial impact from this filing.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001213900-26-070318 |
| Document: 0001213900-26-070318-index-headers.html | 0001213900-26-070318 |
| Document: 0001213900-26-070318-index.html | 0001213900-26-070318 |
| Document: 0001213900-26-070318.txt | 0001213900-26-070318 |
11 reports for UNCY
100% Hit rate @ T+60 Went positive at some point 4 of 4 best @ T+60▲ +38.19%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 3 | $4.22 | awaiting T+60 | — | $3.61 (−14.45%) |
Sep 29, 2026 28d ago | 8-K | $4.55 | awaiting T+60 | — | $3.61 (−20.66%) |
Aug 12, 2026 10w ago | 8-K | $5.39 | awaiting T+60 | — | $3.61 (−33.02%) |
Jul 2, 2026 16w ago | 8-K | $5.73 $4.81 | ▼ −16.06% | ▼ −19.06% | $3.61 (−37.00%) |
Jun 22, 2026 18w ago | DEFA14A | $7.87 $4.71 | ▼ −40.15% | ▼ −41.90% | $3.61 (−54.13%) |
Jun 16, 2026 19w ago | EFFECT | $7.17 $5.31 | ▲ +25.94% | ▲ +26.94% | $3.61 (+49.65%) |
Jun 5, 2026 20w ago | S-3 | $6.66 $5.05 | ▲ +24.17% | ▲ +27.23% | $3.61 (+45.80%) |
May 12, 2026 24w ago | 8-K | $8.17 $5.05 | ▼ −38.19% | ▼ −42.57% | $3.61 (−55.81%) |
May 12, 2026 24w ago | Press Release | $8.17 $5.05 | ▲ +38.19% | ▲ +42.57% | $3.61 (+55.81%) |
Apr 6, 2026 29w ago | 8-K | $6.62 $5.28 | ▼ −20.24% | ▼ −33.71% | $3.61 (−45.47%) |
Showing 10 of 11
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers